肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2021 NICE: 纳武单抗联合伊匹单抗和化疗治疗未经治疗的转移性非小细胞肺癌

2021-09-08 英国国家卫生与临床优化研究所 NICE官网

肺癌转移性非小细胞肺癌

纳武单抗联合伊匹单抗和化疗治疗未经治疗的转移性非小细胞肺癌的循证建议。

中文标题：

2021 NICE: 纳武单抗联合伊匹单抗和化疗治疗未经治疗的转移性非小细胞肺癌

英文标题：

Nivolumab with ipilimumab and chemotherapy for untreated metastatic non-small-cell lung cancer

发布机构：

英国国家卫生与临床优化研究所

发布日期：

2021-09-08

简要介绍：

纳武单抗联合伊匹单抗和化疗治疗未经治疗的转移性非小细胞肺癌的循证建议。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 NICE_ 纳武单抗联合伊匹单抗和化疗治疗未经治疗的转移性非小细胞肺癌.pdf)] GetToolGuiderByIdResponse(projectId=1, id=322ae1c00225a3f6, title=2021 NICE: 纳武单抗联合伊匹单抗和化疗治疗未经治疗的转移性非小细胞肺癌, enTitle=Nivolumab with ipilimumab and chemotherapy for untreated metastatic non-small-cell lung cancer, guiderFrom=NICE官网, authorId=0, author=, summary=纳武单抗联合伊匹单抗和化疗治疗未经治疗的转移性非小细胞肺癌的循证建议。, cover=https://img.medsci.cn/2021114/1636036190020_5579292.jpg, journalId=0, articlesId=null, associationId=85, associationName=英国国家卫生与临床优化研究所, associationIntro=英国国家卫生与临床优化研究所（NICE，National Institute for Health and Clinical Excellence）是NHS的组织，设在伦敦和曼彻斯特。NICE成立于1999年4月1日，目标是确保每个英格兰和威尔士人平等享有NHS医疗的机会。NICE制定指南，设定质量标准，管理国家数据库，为NHS、当地权威部门和其他组织提供指南。, copyright=0, guiderPublishedTime=Wed Sep 08 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p>纳武单抗联合伊匹单抗和化疗治疗未经治疗的转移性非小细胞肺癌<span style="color: #0e0e0e;">的循证建议。</span></p>, tagList=[TagDto(tagId=428, tagName=肺癌), TagDto(tagId=38630, tagName=转移性非小细胞肺癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=24, categoryName=胸心外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=38630, guiderKeyword=转移性非小细胞肺癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1630, appHits=51, showAppHits=0, pcHits=218, showPcHits=1579, likes=0, shares=15, comments=2, approvalStatus=1, publishedTime=Tue Nov 16 23:56:36 CST 2021, publishedTimeString=2021-09-08, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Thu Nov 04 22:35:14 CST 2021, updatedBy=4754896, updatedName=小小医者, updatedTime=Fri Jan 05 10:28:31 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 NICE_ 纳武单抗联合伊匹单抗和化疗治疗未经治疗的转移性非小细胞肺癌.pdf)])
2021 NICE_ 纳武单抗联合伊匹单抗和化疗治疗未经治疗的转移性非小细胞肺癌.pdf
下载请点击：
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1072318, encodeId=b82710e23188a, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b425218918, createdName=147766d0m67暂无昵称, createdTime=Sat Nov 20 19:50:35 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068119, encodeId=6193106811987, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3dd1885795, createdName=ms1812733236525890, createdTime=Mon Nov 08 13:59:51 CST 2021, time=2021-11-08, status=1, ipAttribution=)]
    2021-11-20 147766d0m67暂无昵称

    非常好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1072318, encodeId=b82710e23188a, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b425218918, createdName=147766d0m67暂无昵称, createdTime=Sat Nov 20 19:50:35 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068119, encodeId=6193106811987, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3dd1885795, createdName=ms1812733236525890, createdTime=Mon Nov 08 13:59:51 CST 2021, time=2021-11-08, status=1, ipAttribution=)]
    2021-11-08 ms1812733236525890

    非常好

    0

相关指南

非小细胞肺癌分子残留病灶专家共识

中国抗癌协会肺癌专业委员会 · 2021-06-30

2021 AATS专家共识文件：Ⅰ期非小细胞肺癌考虑行肺叶切除术高危患者的定义和评估

美国胸外科协会(AATS,American Association for Thoracic Surgery) · 2021-07-29

肺癌相关性咳嗽诊疗中国专家共识

中国抗癌协会癌症康复与姑息治疗专业委员会(CRPC) · 2021-09-21

肺癌多学科团队诊疗中国专家共识 2020

中华医学会肿瘤学分会 · 2020-12-09

肺癌和COVID-19大流行：巴西胸部肿瘤小组的建议

巴西胸部肿瘤组织（Brazilian Thoracic Oncology Group） · 2020-09-01

在COVID-19大流行期间接受治疗性放疗的肺癌患者管理共识

暂未更新 · 2020-09-01

拓展阅读

2016 ESMO临床实践指南：转移性非小细胞肺癌的诊断、治疗和随访

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2016-09-20

2018 ESMO临床实践指南：转移性非小细胞肺癌的诊断，治疗和随访

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2018-10-01

2018 AIOM指南：转移性非小细胞肺癌的治疗

意大利肿瘤医学协会(AIOM,Italian Association of Medical Oncology) · 2019-07-01